ezetimibe has been researched along with fondaparinux in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (fondaparinux) | Trials (fondaparinux) | Recent Studies (post-2010) (fondaparinux) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 1,190 | 112 | 559 |
Protein | Taxonomy | ezetimibe (IC50) | fondaparinux (IC50) |
---|---|---|---|
Coagulation factor X | Homo sapiens (human) | 0.011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böcking, W; Bramlage, P; Kirch, W; Mueller, EA | 1 |
1 review(s) available for ezetimibe and fondaparinux
Article | Year |
---|---|
[Innovation instead of imitation -- news in drug therapy].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Anticoagulants; Antineoplastic Agents; Azetidines; Body Weight; Cannabinoid Receptor Antagonists; Cetuximab; Drug Therapy; Ezetimibe; Fondaparinux; Humans; Hypoglycemic Agents; Insulin; Osteoporosis, Postmenopausal; Piperidines; Polysaccharides; Pyrazoles; Rimonabant; Smoking Cessation; Teriparatide; Thromboembolism | 2005 |